Skip to content

A study on differential diagnosis of radiation necrosis and brain tumor recurrence with dual stage Methionine PET/CT

A study on differential diagnosis of radiation necrosis and brain tumor recurrence with dual stage Methionine PET/CT - Dual stage Methionine PET/CT

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000018670
Enrollment
40
Registered
2015-08-14
Start date
2014-10-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain tumor recurrence and radiation necrosis

Interventions

None listed

Sponsors

National Center for Global Health and Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients who undergoes methionine PET/CT to determine whether radiation necrosis or brain tumor recurrence

Exclusion criteria

Exclusion criteria: patients who do not agree to participate patients who have difficulty in stopping moving other patients whom researcher (doctor) judged to exclude.

Design outcomes

Primary

MeasureTime frame
Which is more accurate, the conclusion from early image only and the conclusion from both early image and delayed image are compared. The answer is acquired by the course or the pathology.

Countries

Japan

Contacts

Public ContactMasashi Kameyama

National Center for Global Health and Medicine Division of Nuclear Medicine

kame-tky@umin.ac.jp03-5273-6881

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026